Creator of Hit Skin Booster Rejuran Achieves Billionaire Status Amid K-Beauty Surge

The rise of PharmaResearch, driven by its popular Rejuran injection made from salmon sperm cells, has significantly increased its stock value and turned its founder, Jung Sang-soo, into a billionaire. With a 30% stake, Jung’s net worth is now estimated at $1.2 billion. Based in Gangneung, PharmaResearch specializes in using PDRN and PN for anti-aging treatments, boasting a 56% revenue increase year-over-year. The global anti-aging market’s growth and the popularity of K-beauty are further boosting the company. Investments from private equity firms like CVC Capital are also aiding its expansion, particularly in Southeast Asia.